These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 5355958)
21. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients. Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496 [TBL] [Abstract][Full Text] [Related]
22. [Re-evaluation of anti-Hansenian chemotherapy by long-term study and by experimental and pharmacokinetic criteria]. Carayon A Acta Leprol; 1980; (79):55-65. PubMed ID: 6794334 [No Abstract] [Full Text] [Related]
23. [Sulfones in modern therapy of leprosy]. MARIANO J Arq Min Leprol; 1953 Jan; 13(1):50-3. PubMed ID: 13115261 [No Abstract] [Full Text] [Related]
24. Studies on sulfone resistance in leprosy. I. Detection of cases. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069 [No Abstract] [Full Text] [Related]
25. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?]. Sheskin J; Mückter H; Frankus E Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166 [No Abstract] [Full Text] [Related]
26. Steroid therapy and leprosy. Ramu G Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589 [No Abstract] [Full Text] [Related]
27. [Drug-induced pathomorphosis of skin lesions in leprosy]. Vishnevetskiĭ FE Arkh Patol; 1971; 33(9):70-7. PubMed ID: 4336757 [No Abstract] [Full Text] [Related]
28. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663). Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070 [No Abstract] [Full Text] [Related]
29. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014 [No Abstract] [Full Text] [Related]
31. Supplies of thalidomide for use in leprosy. Loretti A; Barchi E Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585 [No Abstract] [Full Text] [Related]
32. [Present-day specific therapeutic drugs for leprosy]. Languillon J Med Trop (Mars); 1966; 26():Suppl 26:131+. PubMed ID: 4864601 [No Abstract] [Full Text] [Related]
33. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses. Opromolla DV Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085 [No Abstract] [Full Text] [Related]
34. Length of continued treatment of an inactive case of leprosy. Dharmendra Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967 [No Abstract] [Full Text] [Related]
35. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505 [TBL] [Abstract][Full Text] [Related]
36. Unsatisfactory results with thalidomide as a specific treatment for leprosy. Sheskin J; Sagher F; Dorfman M; Schrader-Beielstein HW Isr J Med Sci; 1968; 4(4):901-4. PubMed ID: 5710961 [No Abstract] [Full Text] [Related]